NR1H2 Human Pre-designed siRNA Set A contains three designed siRNAs for NR1H2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NR1H3 Human Pre-designed siRNA Set A contains three designed siRNAs for NR1H3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NR1H4 Human Pre-designed siRNA Set A contains three designed siRNAs for NR1H4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Nr1h4 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Nr1h4 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Nr1h4 Rat Pre-designed siRNA Set A contains three designed siRNAs for Nr1h4 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

NR1I2 Human Pre-designed siRNA Set A contains three designed siRNAs for NR1I2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NR1I3 Human Pre-designed siRNA Set A contains three designed siRNAs for NR1I3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NR2B-selective NMDA receptor antagonist 1 (compound 29) is a potent antagonist of NR1/NR2B receptors, with IC50s of 0.05 μM, 0.73 μM, 2.4 μM to NR1/NR2B NMDA receptor, hERG, α1-AdR, respectivity. NR2B-selective NMDA receptor antagonist 1 exhibites efficient permeability across the blood–brain barrier[1].

NR2C1 Human Pre-designed siRNA Set A contains three designed siRNAs for NR2C1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NR2C2 Human Pre-designed siRNA Set A contains three designed siRNAs for NR2C2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NR2C2AP Human Pre-designed siRNA Set A contains three designed siRNAs for NR2C2AP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NR2E1 Human Pre-designed siRNA Set A contains three designed siRNAs for NR2E1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NR2E3 Human Pre-designed siRNA Set A contains three designed siRNAs for NR2E3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NR2F1 Human Pre-designed siRNA Set A contains three designed siRNAs for NR2F1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NR2F2 Human Pre-designed siRNA Set A contains three designed siRNAs for NR2F2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NR2F2-IN-1 (free base) is a potent and selective orphan nuclear receptor COUP-TFII (NR2F2) inhibitor. NR2F2-IN-1 (free base) substantially inhibits COUP-TFII–driven NGFIA reporter expression. NR2F2-IN-1 (free base) directly binds to the COUP-TFII ligand-binding domain and disrupts COUP-TFII interaction with transcription regulators, including FOXA1, thus repressing COUP-TFII activity on target gene regulation[1].

NR2F2-IN-1 (free base) is a potent and selective orphan nuclear receptor COUP-TFII (NR2F2) inhibitor. NR2F2-IN-1 (free base) substantially inhibits COUP-TFII–driven NGFIA reporter expression. NR2F2-IN-1 (free base) directly binds to the COUP-TFII ligand-binding domain and disrupts COUP-TFII interaction with transcription regulators, including FOXA1, thus repressing COUP-TFII activity on target gene regulation[1].

NR2F2-IN-1 (free base) is a potent and selective orphan nuclear receptor COUP-TFII (NR2F2) inhibitor. NR2F2-IN-1 (free base) substantially inhibits COUP-TFII–driven NGFIA reporter expression. NR2F2-IN-1 (free base) directly binds to the COUP-TFII ligand-binding domain and disrupts COUP-TFII interaction with transcription regulators, including FOXA1, thus repressing COUP-TFII activity on target gene regulation[1].

NR2F2-IN-1 (free base) is a potent and selective orphan nuclear receptor COUP-TFII (NR2F2) inhibitor. NR2F2-IN-1 (free base) substantially inhibits COUP-TFII–driven NGFIA reporter expression. NR2F2-IN-1 (free base) directly binds to the COUP-TFII ligand-binding domain and disrupts COUP-TFII interaction with transcription regulators, including FOXA1, thus repressing COUP-TFII activity on target gene regulation[1].

NR2F2-IN-1 (free base) is a potent and selective orphan nuclear receptor COUP-TFII (NR2F2) inhibitor. NR2F2-IN-1 (free base) substantially inhibits COUP-TFII–driven NGFIA reporter expression. NR2F2-IN-1 (free base) directly binds to the COUP-TFII ligand-binding domain and disrupts COUP-TFII interaction with transcription regulators, including FOXA1, thus repressing COUP-TFII activity on target gene regulation[1].

NR2F6 Human Pre-designed siRNA Set A contains three designed siRNAs for NR2F6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NR3C1 Human Pre-designed siRNA Set A contains three designed siRNAs for NR3C1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Nr3c1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Nr3c1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Nr3c1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Nr3c1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

NR3C2 Human Pre-designed siRNA Set A contains three designed siRNAs for NR3C2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Nr3c2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Nr3c2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Nr3c2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Nr3c2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

NR4A1 Human Pre-designed siRNA Set A contains three designed siRNAs for NR4A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NR4A2 Human Pre-designed siRNA Set A contains three designed siRNAs for NR4A2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NR4A3 Human Pre-designed siRNA Set A contains three designed siRNAs for NR4A3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NR5A1 Human Pre-designed siRNA Set A contains three designed siRNAs for NR5A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NR5A2 Human Pre-designed siRNA Set A contains three designed siRNAs for NR5A2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NR6A1 Human Pre-designed siRNA Set A contains three designed siRNAs for NR6A1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NRAP Human Pre-designed siRNA Set A contains three designed siRNAs for NRAP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NRARP Human Pre-designed siRNA Set A contains three designed siRNAs for NRARP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NRAS Human Pre-designed siRNA Set A contains three designed siRNAs for NRAS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Nras Mouse Pre-designed siRNA Set A contains three designed siRNAs for Nras gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Nras Rat Pre-designed siRNA Set A contains three designed siRNAs for Nras gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

NRBF2 Human Pre-designed siRNA Set A contains three designed siRNAs for NRBF2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NRBP1 Human Pre-designed siRNA Set A contains three designed siRNAs for NRBP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NRCAM Human Pre-designed siRNA Set A contains three designed siRNAs for NRCAM gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NRDC Human Pre-designed siRNA Set A contains three designed siRNAs for NRDC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NRDE2 Human Pre-designed siRNA Set A contains three designed siRNAs for NRDE2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NREP Human Pre-designed siRNA Set A contains three designed siRNAs for NREP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

NRF1 Human Pre-designed siRNA Set A contains three designed siRNAs for NRF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Nrf2 degrader 1 (compound 1) is a PROTAC Nrf2 degrader with anticancer effects. Nrf2 degrader 1 inhibits cancer cells growth for A549 and LK-2 cells with IC50 values of 100 nM and 40 nM, respectively[1].